Skip to main content
OpenTrials
Completed

NCT Number: NCT02490215

Epidemiology of Acute Respiratory Distress Syndrome in Chinese ICUs

The acute respiratory distress syndrome(ARDS)has a high morbidity and mortality in patients admitted to intensive care units(ICUs). It represents a significant public health issue. No large nationwide, multicenters study of ARDS has been conducted in China. The purposes of this study are to analyse: 1)the incidence and outcomes of ARDS in ICU; 2) factors associated the mortality ; and 3) risk factors for development of ARDS .

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Respiratory Distress Syndrome Lung Diseases Respiration Disorders Respiratory Distress Syndrome Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing Hospital of ministry of Health, Beijing, Beijing Municipality, China

Loading trial locations.

About this study

All patients admitted to the participating ICUs during a 6-month period(from January 1, 2015 to July 1,2015 ) will be screened at ICU admission and daily for the occurrence of ARDS ( AECC criteria) for a maximum of 28 days after ICU admission.

Data collection:

  • For all patients, Demographic characteristics, admission category, the patient source intervention during ICU , APACHEII , SOFA score and discharge information will be collected
  • For patients with ARDS, data about ABG , parameters of MV, hemodynamic on day0 to day7 and last day of MV will be collected.
  • For patients without ARDS at ICU admission, data about risk factor for ARDS ,such as LIPS score, parameters of MV , and fluid balance on ICU day0 to day7 will be collected.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patients age >18 yrs admitted to 24 participating ICUs

Exclusion criteria

No patients should be excluded (regardless of age, underlying disease, life expectancy, etc).

Treatment and study plan

Primary outcomes

  1. incidence of acute respiratory distress syndrome (ARDS)

    Time frame: from ICU admission to 28-day of ICU stay

    incidence of ARDS = the number of patients developing ARDS during ICU / the total number of patients admitted to ICU

Secondary outcomes

  1. ICU mortality of patients with ARDS

    Time frame: followed up to 3 months after inclusion or to ICU discharge, whichever occurred first

  2. hospital mortality of patients with ARDS

    Time frame: followed up to 3 months after inclusion or to hospital discharge, whichever occurred first

Sponsors and collaborators

Lead sponsor

Peking Union Medical College Hospital

Other

Registry information

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Jul 3, 2015
Registry last updated
Jun 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.